Last year, a number of new records were set, and today, we take a look at some of the top trading trends from 2024. Markets rallied to new all-time highs. As interest rates fell, ...

We are committed to providing an accessible digital experience for all users by working to achieve conformance under Web Content Accessibility Guidelines (WCAG) 2.2 Level AA. To accomplish this goal, ...

Written by Nikolaus Hoffman for Bitcoin Magazine -> ...

The global financial system has reached unprecedented levels of complexity, but banks now have better tools available to tackle these challenges head-on. A new report released today, January 22, from ...

The analysts forecast only 8.5% growth in 2025 despite the robust performance of cloud and AI infrastructure segments in the first fiscal half and building momentum in the services segment. The ...

At issue is the Tax Cuts and Jobs Act of 2017, which was a hallmark of Trump’s first term. Abbreviated TCJA, the law made sweeping changes to the U.S. tax code that slashed the average person’s income ...

About This EventThe Council of Institutional Investors staff, board of directors and local member representatives visit the Nasdaq MarketSite in Times Square, to commemorate CII’s 40th anniversary, ...

The transportation average has trended higher for the last two years and is set to reach new highs this year. The price action in early 2025 is bullish, confirming the trend with a strong signal, ...

The semiconductor industry is experiencing rapid growth, driven by an increase in demand due to rapid technological advancements. This surge in demand presents a significant opportunity for investors, ...

Institutional buyers from Geode Capital Management decided to boost their holdings in Xometry stock by 4.3% as of November 2024, bringing their net position to a high of $18.3 million today. They were ...

The price of gold and the SPDR Gold Shares ETF (NYSEARCA: GLD) delivered exceptional returns in 2024, with GLD surging over 30%, outperforming the benchmark and broader market. This trend has ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...